Skip to content

UCB PHARMA

Active
Public limited companyfounded 1968active for 58 yearsResearchdreef 60, 1070 Anderlecht, BelgiumKBO/BCE: BE 0403.096.168
Summary

UCB PHARMA has been active since 1968 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €16.23bn and a net result of €4.24bn. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 84% of 6,081 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
UCB PHARMAActiveChecked score 94/100
Risk analysis ReportCompare

Group and network

Part of the group U C B 12 companies Group, risk and exposure

Holdings and subsidiaries

12 holdings · 13 subsidiaries in the tree

Holdings 12

Show 2 more holdings
Stated earlier (1)

An older source named these holdings; newer accounts no longer list them.

All subsidiaries, including indirect ones 13

Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.

  • UCB Belgium 100%1 subsidiary
  • UCB BIOPHARMA 100%
  • UCB Farchim SA (AG - Ltd)CH 100%
  • UCB Holdings, Inc.US 100%
  • UCB Nordic ASDK 100%
  • UCB Pharma A.S.NO 100%
  • UCB Pharma AbSE 100%
  • UCB Pharma B.V.NL 100%
  • UCB Pharma GmbH AustriaAT 100%
  • UCB Pharma OyFI 100%
  • UCB GmbHDE 94.79%
  • UCB PHARMA GMBHDE consolidated

According to the 2025 annual accounts of UCB PHARMA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Connections & network

7 connected companies
Depth
Jean-Christophe Tellier, Shared director JTJean-ChristopheTellierSolvac, via Jean-Christophe Tellier SSolvacACCESS & PARTNERS, Shared director APACCESS &PARTNERSCadastre et Inspection Télévisuelle des réseaux, Shared director CECadastre etInspection…FEDERATION BELGE DES INDUSTRIES CHIMIQUES ET DES SCIENCES DE LA VIE, Shared director FBFEDERATIONBELGE DES…FONDS DE PREVOYANCE UCB - VOORZORGSFONDS UCB, 2 shared directors FDFONDS DEPREVOYANCE…Fédération des Employeurs des Institutions ambulatoires pour Toxicomanes, Shared director FDFédération desEmployeurs…UMICORE FINANCIAL SERVICES, Shared director UFUMICOREFINANCIAL…UCB PHARMA UCB PHARMA0403.096.168
Shared directors
This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
Solvac
via Jean-Christophe Tellier · Director
→
ACCESS & PARTNERS
Shared director
→
Cadastre et Inspection Télévisuelle des réseaux
Shared director
→
FEDERATION BELGE DES INDUSTRIES CHIMIQUES ET DES SCIENCES DE LA VIE
Shared director
→
Show 3 more companies with a shared director
FONDS DE PREVOYANCE UCB - VOORZORGSFONDS UCB
Shared director
→
Fédération des Employeurs des Institutions ambulatoires pour Toxicomanes
Shared director
→
UMICORE FINANCIAL SERVICES
Shared director
→

Board mandates elsewhere

1 board mandate
Board mandates of this companythis company sits on their board1
ASSOCIATION GENERALE DE L'INDUSTRIE DU MEDICAMENT - ALGEMENE VERENIGING VAN DE GENEESMIDDELENINDUSTRIE
1 location

We would like to set cookies. That happens only with your consent. What we measure